Company Snapshot Home > Equity > Corporate Information > Company Snapshot
|
|
| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
178.75
|
|
Change (%)
|
16.25 (10.00%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
165.00
-
178.75
|
|
52-Week Range (RS)
|
72.25
-
204.95
|
|
Beta (1 Year)
|
0.51
|
|
|
|
|
|
| News |
|
Corporate Details |
| Bafna Pharmaceuticals standalone net profit rises 109.92% in the March 2026 quarter |
| Bafna Pharmaceuticals announces board meeting date |
| Bafna Pharmaceuticals standalone net profit rises 93.68% in the December 2025 quarter |
| Bafna Pharmaceuticals announces board meeting date |
|
|
|
| Incoporation Year : 1995 |
| Chairman : Ravichandran Chitra |
| Ownership Group : Indian Private |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Formulations |
| Registered Office |
Bafna Pharmaceuticals Ltd
Bafna Towers New No 68,
Old No 299 Thambu Chetty St,
Chennai,
Tamil Nadu-600001 |
Phone:91-44-25267517/25270992/4267755
Fax:91-44-25231264/42677599 |
| E-Mail : cs@bafnapharma.com; info@bafnapharma.com |
| URL : http://www.bafnapharma.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
29-May-2026 |
134.00 |
21.27 |
| 1Month |
04-May-2026 |
137.00 |
18.61 |
| 3Month |
04-Mar-2026 |
108.90 |
49.22 |
| 6Month |
05-Dec-2025 |
149.40 |
8.77 |
| 1Year |
04-Jun-2025 |
74.95 |
116.81 |
|
|
|
|
| Mutual Funds Holding |
|
| No Data Found |
|
|
|
| Groups : Pharmaceuticals - Indian - Formulations |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Torrent Pharmaceuticals Ltd |
4,418.70 |
1.87 |
4,714.50 |
3,109.10 |
146,805.79 |
| Ajanta Pharma Ltd |
2,977.60 |
1.02 |
3,314.80 |
2,335.00 |
36,826.65 |
| Gland Pharma Ltd |
2,272.15 |
2.31 |
2,391.25 |
1,575.00 |
36,635.90 |
| Rubicon Research Ltd |
1,202.15 |
-7.29 |
1,371.75 |
571.00 |
21,363.17 |
| ERIS Lifesciences Ltd |
1,361.05 |
-0.48 |
1,909.55 |
1,237.90 |
18,949.77 |
|
|
|
|